Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01991743 · ClinicalTrials.gov registry record · NA
A Trial Comparing Combined Spinal- Epidural Dosing Strategies for External Cephalic Version
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 240
- Enrollment target
NCT01991743: Completed NA study, sponsored by Northwestern University.
NCT01991743 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 240 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01991743, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
Study Summary
We plan to conduct a prospective, single blinded, randomized clinical trial to assess the impact of combined spinal-epidural dosing on the success rate of, and patient satisfaction during, external version for breech fetal position and the incidence of vaginal vs. Cesarean delivery. The research aim of this project is to determine the ideal neuraxial dosing strategy to maximize success of external cephalic version (ECV). The research questions, does a combined spinal-epidural (CSE) of a higher dose result in greater success in converting a breech presentation to vertex during external cephalic version (ECV). The hypotheses of this project is that CSE at higher dose will result in greater ECV success than analgesic dosing. The research significance:Increasing the success and comfort of ECV for fetal malpresentation may help decrease the cesarean section rate.
Primary Outcome
Rates of successful version evaluated among the 4 dose groups.
Interventions
- DRUG Group 2.5
- DRUG Group 5
- DRUG Group 7.5
- DRUG Group 10
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2011-05 |
| Est. Completion | 2017-01 |
| Phase | NA |
What the finished NCT01991743 record still lists
NCT01991743 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 4 interventions - of which Group 2.5 is the first listed.
NCT01991743 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01991743 about?
NCT01991743 is a clinical study titled "A Trial Comparing Combined Spinal- Epidural Dosing Strategies for External Cephalic Version". We plan to conduct a prospective, single blinded, randomized clinical trial to assess the impact of combined spinal-epidural dosing on the success rate of, and patient satisfaction during, external version for breech fetal position and the incidence of vaginal vs. Cesarean delivery. The research ai...
What is the current status of trial NCT01991743?
This trial is currently completed. It is a NA study. The enrollment target is 240 participants. The study started on 2011-05. Estimated completion is 2017-01.
What interventions are being tested in trial NCT01991743?
The interventions under investigation include: Group 2.5 (DRUG), Group 5 (DRUG), Group 7.5 (DRUG), Group 10 (DRUG).
Who is sponsoring clinical trial NCT01991743?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01991743's enrollment target sits among peer trials
240 440th of 2000 higher than 1,542 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia